HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
about
Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifsPossession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infectionDNA typing of HLA class II genes (HLA-DR, -DQ and -DP) in Japanese patients with histiocytic necrotizing lymphadenitis (Kikuchi's disease)Overcoming Barriers to Cervical Cancer Screening Among Asian American WomenCervical carcinoma in Surinam. Incidence and staging of cervical carcinoma between 1989 and 1994.Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancerHuman leukocyte antigens and cancer: is it in our genes?Genetic susceptibility to HPV infection and cervical cancer.Epitope design of L1 protein for vaccine production against Human Papilloma Virus types 16 and 18Combination treatment with intralesional cidofovir and viral-DNA vaccination cures large cottontail rabbit papillomavirus-induced papillomas and reduces recurrences.Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responsesAmino acid residues in the carboxy-terminal region of cottontail rabbit papillomavirus E6 influence spontaneous regression of cutaneous papillomas.A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosisAssociation of p21 SNPs and risk of cervical cancer among Chinese women.A real-time polymerase chain reaction assay for the rapid identification of the autoimmune disease-associated allele HLA-DQB1*0602.Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection.Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles.Molecular events in uterine cervical cancer.A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice.Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence.Molecular analysis of HLA-DQB1 alleles in childhood common acute lymphoblastic leukaemia.Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.Association between HLA DQB1 * 03 and cervical intra-epithelial neoplasiaDetection of genital human papillomavirus by single-tube nested PCR and type-specific oligonucleotide hybridization.Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British womenHuman papillomavirus vaccines for the treatment of cervical cancer.New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer.Vaccines against human papillomavirus: perspectives for controlling cervical cancer.Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.Nanoparticles for transcutaneous vaccination.Association between human leukocyte antigen class II alleles and genotype of Borrelia burgdorferi in patients with early lyme diseaseChronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic miceHuman papillomavirus infection and the risk of cervical cancer in Japan.Benefits of a continuous therapy for cancer patients with a novel adoptive cell therapy by cascade priming (CAPRI).Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma.Activated monocytes prime naïve T cells against autologous cancer: vigorous cancer destruction in vitro and in vivo.
P2860
Q23923585-3C079468-E68A-44DC-844D-CCAB988A0B33Q24682861-C626ADB6-CDE4-4E42-99E7-AD773F500977Q28145812-6A903C59-B1DC-4C80-9F23-3F9661BE01D6Q28389399-C1B56B66-C319-436E-9459-F9C9212D8285Q29354137-C4FBE0F7-FC63-4DCA-BF62-49788ECD44BDQ33362569-F9C084C2-8D3E-420D-A694-22441A11B0E2Q33695538-92E049E9-8943-442F-A333-0D2FBE1E4ECBQ33716371-B0D295AD-AA14-4811-80E9-7FFC3A3CA601Q33743226-6AD16EB6-FCFB-409D-B98F-9A535732E77DQ33981920-E0534853-5527-4AEA-8FE6-1379B6C60955Q34140188-FC981359-3128-4DD8-8FB1-ADD1504846A8Q34190681-FCFD6409-2A7A-4A11-9859-78E3DE0FECD8Q34359718-58F9E63F-39FB-4B6D-B1B7-9EA666D7A770Q34397564-343DEB66-A42F-406A-B1DC-71551C354DE8Q34466134-2C9992CB-7B99-42C3-BF2F-66805E6BCE26Q34508620-DB9248C3-0FF6-431C-95AF-24FC968445FCQ34523172-75A5B1F1-DAFE-429E-A690-54B1DCE09FD6Q34764016-4141CC78-C821-4A09-8E9F-809BBE9452FAQ35298122-9BECC853-487E-4739-B322-453808C1D4EEQ35562096-7DA53C7D-5586-4C7D-A13C-7BFDFC3914B1Q35749285-9E8F5696-CEE8-4F57-AF35-2E9D9EC6FAA4Q35782743-E034C2BD-D716-4120-81E0-094EBC7C9D59Q35861907-BEEAD8CA-1236-4B27-85D7-F43B906B6C32Q36134654-211BD98A-6DDD-445B-A3B7-9BB5AE4D60EDQ36262929-A217930A-29CA-46D0-B392-68CC9FB41781Q36403535-407EE3CC-F40F-4CF8-A7BB-F6AD18C53DF8Q36437492-435E7DF2-E16F-4527-8914-B9E3E6847817Q36523281-82FEB59E-E106-48FA-A123-80DABD9E1493Q36641670-5ED69E61-DB2F-455D-B527-3C07353A7A2AQ36690278-6648D0BE-BDFA-410C-AC8F-3BD87CE6B07DQ36877132-1CEF57CD-9E49-44C3-91A8-E0298E16BECEQ36899058-AF5D569D-4180-44F3-BF5F-878E3343D063Q36974722-CBB0922E-C4F2-46B7-B283-6BCFA3F7848EQ37274692-57444009-862F-462A-BB9D-5B25273535CAQ37419565-232FBC84-E2F5-4D73-93F3-AEB6963B20E8Q37680979-790CC924-96F0-4A4C-97D9-662623C6B931Q38038280-78E139BF-A530-49F2-82D6-31A799CDBB6AQ38206816-53202375-7078-41C8-841E-A8BFC628500AQ38479363-0B0C3E7D-CA55-4ADD-808B-0CB4426B0481Q39458843-2F72404D-4595-46B9-857F-AC391BC94CCD
P2860
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
@ast
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
@en
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
@nl
type
label
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
@ast
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
@en
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
@nl
prefLabel
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
@ast
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
@en
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
@nl
P2093
P2860
P356
P1433
P1476
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
@en
P2093
P2860
P2888
P304
P356
10.1038/NG0294-157
P407
P577
1994-02-01T00:00:00Z